Giulia Maddalena

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes

Fotios Loupakis, Ilaria Depetris, Paola Biason et al. · The Oncologist · 2020 · 112 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden

Filippo Pietrantonio, Fotios Loupakis, Giovanni Randon et al. · The Oncologist · 2020 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status

Fotios Loupakis, Giulia Maddalena, Ilaria Depetris et al. · Journal for ImmunoTherapy of Cancer · 2019 · 36 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors

Claire Gallois, Matteo Landi, Marine Sroussi et al. · Clinical Cancer Research · 2023 · 31 citations · Full text

Medicine, Cancer Biology, Oncology +17

Negative Ultraselection of Patients With <i>RAS</i>/<i>BRAF</i> Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy

Giovanni Randon, Giulia Maddalena, Marco Maria Germani et al. · JCO Precision Oncology · 2022 · 30 citations · Full text

Medicine, Genetics, Oncology +17